Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

by Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Merot, J.-L., Miles, D., Coudert, Bruno, Errihani, Hassan, Dalenc, Florence, Barrett, Sophie, Beato, Carlos, Hu, Xichun, Perrin, Christophe, Ettl, Johannes, Li, Huiping, Cariello, Anna, Frassoldati, Antonio, Wronski, Andrzej, Menjón Beltrán, Salomón, Cicin, Irfan, Schmid, Peter, Juarez, Alejandro, Matos, Erika, Uslu, Ruchan, Wildiers, Hans, Bourgeois, Hugues, von Schumann, Raquel, Wojtukiewicz, Marek, Peron, Yann Izarzugaza, Wheatley, Duncan, De Boer, Richard, Jerusalem, Guy, Latini, Luciano, Barnadas Molins, Agusti, Martinez, Eduardo, Baird, Richard, McCarthy, Nicole, Greil, Richard, Juhasz-Boess, Ingolf, de la Cruz, Luis Ruiz, Del Val, Olga, Azribi, Fathi, Turner, Nicholas, Andrade, Jurandyr, Bernstein, Vanessa, Rayson, Daniel, Gennari, Alessandra, El-Saghir, Nagi, Kukulska, Monika, Pelaez, Ignacio, del Mar Gordon, Maria, Varughese, Mohini, Levitt, Nicola, Singer, Christian, Efremidou, Anna, Evron, Ella, Luigi, Cavanna, Garcia, Andres, Lopez Ceballos, Maria Helena, García, María, Arcediano, Alberto, McAdam, Karen, Humphreys, Alison, de Grève, Jacques, Joy, Anil, Sehdev, Sandeep, Kütner, Riina, Laplaige, Philippe, Christensen, Bernd, Fountzilas, Georgios, Fried, Georgeta, Giacobino, Alice, Bonetti, Andrea, Van der Velden, Annette, Vrijaldenhoven, Suzan, Andres Conejero, Raquel, Murias, Adolfo, Saura, Salvador, Poole, Christopher, Woodward, Natasha, Califaretti, Nadia, Jiang, Jun, Padrik, Peeter, Saarni, Outi, Genet, Dominique, Catala, Stéphanie, Facchini, Thomas, Repp, Roland, Schroeder, Willibald, Kahan, Zsuzsanna, Rosengarten, Ora, Alabiso, Oscar, Van de Wouw, Yes, Sousa, Gabriela, Jesús Florián Jerico, Marta Santisteban, Torrego, Juan Carlos, Rodriguez, Cesar, Llorca, Cristina, Galán, Antonio, Rodríguez, Robinson, Alonso, Isabel
Published in Annals of oncology